Related references
Note: Only part of the references are listed.Noncoding RNAs as potential biomarkers for DIPG diagnosis and prognosis: XIST and XIST-210 involvement
M. A. Velazquez-Flores et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
LncRNA ZNF667-AS1 Promotes ABLIM1 Expression by Adsorbing microRNA-1290 to Suppress Nasopharyngeal Carcinoma Cell Progression
Xi Chen et al.
ONCOTARGETS AND THERAPY (2020)
A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma
Jinlan Huang et al.
DISEASE MARKERS (2020)
Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
Alja Zottel et al.
CANCERS (2020)
LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis
Jun Xin et al.
HUMAN CELL (2020)
Noncoding RNAs: the shot callers in tumor immune escape
Lei Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Insular glioma surgery: an evolution of thought and practice
Shawn L. Hervey-Jumper et al.
JOURNAL OF NEUROSURGERY (2019)
Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation
Yong-Jie Li et al.
MOLECULAR ONCOLOGY (2019)
Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses
Feng Yuan et al.
DISEASE MARKERS (2019)
The Value of lncRNA GHET1 as a Prognostic Factor for Survival of Chinese Cancer Outcome: A Meta-Analysis
Junying Song et al.
DISEASE MARKERS (2019)
Long non-coding RNA RNCR3 promotes glioma progression involving the Akt/GSK-3β pathway
Bing Zhu et al.
ONCOLOGY LETTERS (2019)
ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme
Zheng Zhao et al.
DISEASE MARKERS (2019)
Molecular Pathogenesis of Low-Grade Glioma
Devin Bready et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2019)
Aberrant hypermethylation-mediated downregulation of antisense lncRNA ZNF667-AS1 and its sense gene ZNF667 correlate with progression and prognosis of esophageal squamous cell carcinoma
Zhiming Dong et al.
CELL DEATH & DISEASE (2019)
Primary brain tumours in adults
Sarah Lapointe et al.
LANCET (2018)
Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis
Rong-Xin Geng et al.
DISEASE MARKERS (2018)
Non-coding RNAs as drug targets
Masayuki Matsui et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Current and future strategies for treatment of glioma
Nancy Ann Oberheim Bush et al.
NEUROSURGICAL REVIEW (2017)
Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes
Lukas Vrba et al.
JOURNAL OF BREAST CANCER (2017)
Glioma Subclassifications and Their Clinical Significance
Ricky Chen et al.
NEUROTHERAPEUTICS (2017)
LncRNA as a Therapeutic Target for Angiogenesis
Mohan M. Kumar et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
LncRNA-ATB: An indispensable cancer-related long noncoding RNA
Jinglin Li et al.
CELL PROLIFERATION (2017)
Revealing protein-lncRNA interaction
Fabrizio Ferre et al.
BRIEFINGS IN BIOINFORMATICS (2016)
A lincRNA connected to cell mortality and epigenetically-silenced in most common human cancers
Lukas Vrba et al.
EPIGENETICS (2015)
The epidemiology of glioma in adults: a state of the science review
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Brainstem Glioma: A Review
Sean A. Grimm et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2013)
Share Paper
